<?xml version="1.0" ?>
<document id="fdd06eeb020a963754fee36852a5918a93f7856d">
  <chunk id="fdd06eeb020a963754fee36852a5918a93f7856d.c0" text="Initial Antihypertensive Prescription and Switching: A 5 Year Cohort Study from 250,851 Patients">
    <entity charOffset="8-24" id="fdd06eeb020a963754fee36852a5918a93f7856d.c0.e0" ontology_id="CHEBI_35674" text="Antihypertensive" type="chemical"/>
    <entity charOffset="62-68" id="fdd06eeb020a963754fee36852a5918a93f7856d.c0.e1" ontology_id="CHEBI_34935" text="Cohort" type="chemical"/>
    <pair e1="fdd06eeb020a963754fee36852a5918a93f7856d.c0.e0" e2="fdd06eeb020a963754fee36852a5918a93f7856d.c0.e1" id="fdd06eeb020a963754fee36852a5918a93f7856d.c0.p0" relation="true"/>
  </chunk>
  <chunk id="fdd06eeb020a963754fee36852a5918a93f7856d.c1" text="Purpose: Adverse effects of antihypertensive therapy incur substantial cost. We evaluated whether any major classes of antihypertensive drugs were significantly associated with switching as a proxy measure of medication side effects in a large Chinese population in Hong Kong.">
    <entity charOffset="28-44" id="fdd06eeb020a963754fee36852a5918a93f7856d.c1.e0" ontology_id="CHEBI_35674" text="antihypertensive" type="chemical"/>
    <entity charOffset="119-135" id="fdd06eeb020a963754fee36852a5918a93f7856d.c1.e1" ontology_id="CHEBI_35674" text="antihypertensive" type="chemical"/>
    <entity charOffset="119-141" id="fdd06eeb020a963754fee36852a5918a93f7856d.c1.e2" ontology_id="CHEBI_35674" text="antihypertensive drugs" type="chemical"/>
    <entity charOffset="136-141" id="fdd06eeb020a963754fee36852a5918a93f7856d.c1.e3" ontology_id="CHEBI_23888" text="drugs" type="chemical"/>
    <pair e1="fdd06eeb020a963754fee36852a5918a93f7856d.c1.e0" e2="fdd06eeb020a963754fee36852a5918a93f7856d.c1.e2" id="fdd06eeb020a963754fee36852a5918a93f7856d.c1.p0" relation="true"/>
    <pair e1="fdd06eeb020a963754fee36852a5918a93f7856d.c1.e0" e2="fdd06eeb020a963754fee36852a5918a93f7856d.c1.e3" id="fdd06eeb020a963754fee36852a5918a93f7856d.c1.p1" relation="true"/>
    <pair e1="fdd06eeb020a963754fee36852a5918a93f7856d.c1.e1" e2="fdd06eeb020a963754fee36852a5918a93f7856d.c1.e2" id="fdd06eeb020a963754fee36852a5918a93f7856d.c1.p2" relation="true"/>
    <pair e1="fdd06eeb020a963754fee36852a5918a93f7856d.c1.e1" e2="fdd06eeb020a963754fee36852a5918a93f7856d.c1.e3" id="fdd06eeb020a963754fee36852a5918a93f7856d.c1.p3" relation="true"/>
    <pair e1="fdd06eeb020a963754fee36852a5918a93f7856d.c1.e2" e2="fdd06eeb020a963754fee36852a5918a93f7856d.c1.e3" id="fdd06eeb020a963754fee36852a5918a93f7856d.c1.p4" relation="true"/>
  </chunk>
  <chunk id="fdd06eeb020a963754fee36852a5918a93f7856d.c2" text="Methods: From a clinical database, all adult patients newly prescribed an antihypertensive mono-therapy in Hong Kong between the years 2001-2003 and 2005 were included. Those who paid only one visit, died or stayed in the cohort for ,180 days after the prescription, or prescribed more than one antihypertensive agent were excluded. The factors associated with switching at 180 days were evaluated by multivariate regression analyses. Age, gender, payment status, service type, district of residence, drug class, systolic and diastolic blood pressure levels were predictor variables.">
    <entity charOffset="74-90" id="fdd06eeb020a963754fee36852a5918a93f7856d.c2.e0" ontology_id="CHEBI_35674" text="antihypertensive" type="chemical"/>
    <entity charOffset="222-228" id="fdd06eeb020a963754fee36852a5918a93f7856d.c2.e1" ontology_id="CHEBI_34935" text="cohort" type="chemical"/>
    <entity charOffset="295-311" id="fdd06eeb020a963754fee36852a5918a93f7856d.c2.e2" ontology_id="CHEBI_35674" text="antihypertensive" type="chemical"/>
    <entity charOffset="295-317" id="fdd06eeb020a963754fee36852a5918a93f7856d.c2.e3" ontology_id="CHEBI_35674" text="antihypertensive agent" type="chemical"/>
    <entity charOffset="501-505" id="fdd06eeb020a963754fee36852a5918a93f7856d.c2.e4" ontology_id="CHEBI_23888" text="drug" type="chemical"/>
    <pair e1="fdd06eeb020a963754fee36852a5918a93f7856d.c2.e0" e2="fdd06eeb020a963754fee36852a5918a93f7856d.c2.e1" id="fdd06eeb020a963754fee36852a5918a93f7856d.c2.p0" relation="true"/>
    <pair e1="fdd06eeb020a963754fee36852a5918a93f7856d.c2.e0" e2="fdd06eeb020a963754fee36852a5918a93f7856d.c2.e3" id="fdd06eeb020a963754fee36852a5918a93f7856d.c2.p1" relation="true"/>
    <pair e1="fdd06eeb020a963754fee36852a5918a93f7856d.c2.e0" e2="fdd06eeb020a963754fee36852a5918a93f7856d.c2.e4" id="fdd06eeb020a963754fee36852a5918a93f7856d.c2.p2" relation="true"/>
    <pair e1="fdd06eeb020a963754fee36852a5918a93f7856d.c2.e1" e2="fdd06eeb020a963754fee36852a5918a93f7856d.c2.e2" id="fdd06eeb020a963754fee36852a5918a93f7856d.c2.p3" relation="true"/>
    <pair e1="fdd06eeb020a963754fee36852a5918a93f7856d.c2.e1" e2="fdd06eeb020a963754fee36852a5918a93f7856d.c2.e3" id="fdd06eeb020a963754fee36852a5918a93f7856d.c2.p4" relation="true"/>
    <pair e1="fdd06eeb020a963754fee36852a5918a93f7856d.c2.e1" e2="fdd06eeb020a963754fee36852a5918a93f7856d.c2.e4" id="fdd06eeb020a963754fee36852a5918a93f7856d.c2.p5" relation="true"/>
    <pair e1="fdd06eeb020a963754fee36852a5918a93f7856d.c2.e2" e2="fdd06eeb020a963754fee36852a5918a93f7856d.c2.e3" id="fdd06eeb020a963754fee36852a5918a93f7856d.c2.p6" relation="true"/>
    <pair e1="fdd06eeb020a963754fee36852a5918a93f7856d.c2.e2" e2="fdd06eeb020a963754fee36852a5918a93f7856d.c2.e4" id="fdd06eeb020a963754fee36852a5918a93f7856d.c2.p7" relation="true"/>
    <pair e1="fdd06eeb020a963754fee36852a5918a93f7856d.c2.e3" e2="fdd06eeb020a963754fee36852a5918a93f7856d.c2.e4" id="fdd06eeb020a963754fee36852a5918a93f7856d.c2.p8" relation="true"/>
  </chunk>
  <chunk id="fdd06eeb020a963754fee36852a5918a93f7856d.c3" text="Results: From 250,851 subjects, 159,813 patients were eligible. A total of 6,163 (3.9%) switched their medications within 180 days. Patients prescribed thiazide diuretics had the highest switching rate (5.6%), followed by ACEIs (4.5%), CCBs (4.4%) and beta-blockers (3.2%). When compared with ACEIs, patients on thiazide diuretics were significantly more likely to be switchers (adjusted odds ratio [AOR] 1.49, 95% C.I. 1.31-1.69, p,0.001), whilst patients prescribed CCBs and beta-blockers were similarly likely to have switching. Following these patients up for 5 years showed that thiazide had the most marked increase in switching rate.">
    <entity charOffset="152-160" id="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e0" ontology_id="CHEBI_50264" text="thiazide" type="chemical"/>
    <entity charOffset="161-170" id="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e1" ontology_id="CHEBI_35498" text="diuretics" type="chemical"/>
    <entity charOffset="252-265" id="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e2" ontology_id="CHEBI_35530" text="beta-blockers" type="chemical"/>
    <entity charOffset="312-320" id="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e3" ontology_id="CHEBI_50264" text="thiazide" type="chemical"/>
    <entity charOffset="321-330" id="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e4" ontology_id="CHEBI_35498" text="diuretics" type="chemical"/>
    <entity charOffset="477-490" id="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e5" ontology_id="CHEBI_35530" text="beta-blockers" type="chemical"/>
    <entity charOffset="584-592" id="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e6" ontology_id="CHEBI_50264" text="thiazide" type="chemical"/>
    <pair e1="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e0" e2="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e1" id="fdd06eeb020a963754fee36852a5918a93f7856d.c3.p0" relation="true"/>
    <pair e1="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e0" e2="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e2" id="fdd06eeb020a963754fee36852a5918a93f7856d.c3.p1" relation="true"/>
    <pair e1="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e0" e2="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e4" id="fdd06eeb020a963754fee36852a5918a93f7856d.c3.p2" relation="true"/>
    <pair e1="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e0" e2="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e5" id="fdd06eeb020a963754fee36852a5918a93f7856d.c3.p3" relation="true"/>
    <pair e1="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e1" e2="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e2" id="fdd06eeb020a963754fee36852a5918a93f7856d.c3.p4" relation="true"/>
    <pair e1="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e1" e2="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e3" id="fdd06eeb020a963754fee36852a5918a93f7856d.c3.p5" relation="true"/>
    <pair e1="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e1" e2="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e5" id="fdd06eeb020a963754fee36852a5918a93f7856d.c3.p6" relation="true"/>
    <pair e1="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e1" e2="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e6" id="fdd06eeb020a963754fee36852a5918a93f7856d.c3.p7" relation="true"/>
    <pair e1="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e2" e2="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e3" id="fdd06eeb020a963754fee36852a5918a93f7856d.c3.p8" relation="true"/>
    <pair e1="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e2" e2="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e4" id="fdd06eeb020a963754fee36852a5918a93f7856d.c3.p9" relation="true"/>
    <pair e1="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e2" e2="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e6" id="fdd06eeb020a963754fee36852a5918a93f7856d.c3.p10" relation="true"/>
    <pair e1="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e3" e2="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e4" id="fdd06eeb020a963754fee36852a5918a93f7856d.c3.p11" relation="true"/>
    <pair e1="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e3" e2="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e5" id="fdd06eeb020a963754fee36852a5918a93f7856d.c3.p12" relation="true"/>
    <pair e1="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e4" e2="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e5" id="fdd06eeb020a963754fee36852a5918a93f7856d.c3.p13" relation="true"/>
    <pair e1="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e4" e2="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e6" id="fdd06eeb020a963754fee36852a5918a93f7856d.c3.p14" relation="true"/>
    <pair e1="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e5" e2="fdd06eeb020a963754fee36852a5918a93f7856d.c3.e6" id="fdd06eeb020a963754fee36852a5918a93f7856d.c3.p15" relation="true"/>
  </chunk>
  <chunk id="fdd06eeb020a963754fee36852a5918a93f7856d.c4" text="Conclusions: The higher rates of switching among thiazide diuretics in this study might raise a probably greater incidence of their adverse effects in this Chinese population, yet other factors might also influence switching rates. Patients prescribed thiazide diuretics for longer term should be observed for their intolerability.">
    <entity charOffset="49-57" id="fdd06eeb020a963754fee36852a5918a93f7856d.c4.e0" ontology_id="CHEBI_50264" text="thiazide" type="chemical"/>
    <entity charOffset="58-67" id="fdd06eeb020a963754fee36852a5918a93f7856d.c4.e1" ontology_id="CHEBI_35498" text="diuretics" type="chemical"/>
    <entity charOffset="252-260" id="fdd06eeb020a963754fee36852a5918a93f7856d.c4.e2" ontology_id="CHEBI_50264" text="thiazide" type="chemical"/>
    <entity charOffset="261-270" id="fdd06eeb020a963754fee36852a5918a93f7856d.c4.e3" ontology_id="CHEBI_35498" text="diuretics" type="chemical"/>
    <pair e1="fdd06eeb020a963754fee36852a5918a93f7856d.c4.e0" e2="fdd06eeb020a963754fee36852a5918a93f7856d.c4.e1" id="fdd06eeb020a963754fee36852a5918a93f7856d.c4.p0" relation="true"/>
    <pair e1="fdd06eeb020a963754fee36852a5918a93f7856d.c4.e0" e2="fdd06eeb020a963754fee36852a5918a93f7856d.c4.e3" id="fdd06eeb020a963754fee36852a5918a93f7856d.c4.p1" relation="true"/>
    <pair e1="fdd06eeb020a963754fee36852a5918a93f7856d.c4.e1" e2="fdd06eeb020a963754fee36852a5918a93f7856d.c4.e2" id="fdd06eeb020a963754fee36852a5918a93f7856d.c4.p2" relation="true"/>
    <pair e1="fdd06eeb020a963754fee36852a5918a93f7856d.c4.e2" e2="fdd06eeb020a963754fee36852a5918a93f7856d.c4.e3" id="fdd06eeb020a963754fee36852a5918a93f7856d.c4.p3" relation="true"/>
  </chunk>
</document>
